| Дата випуску | Назва | Автор(и) |
| 2020 | Bone turnover biomarkers, disease activity, and MRI changes of sacroiliac joints in patients with spondyloarthritis | Iaremenko, O.; Shynkaruk, I.; Fedkov, D.; Iaremenko, K.; Petelytska, L. |
| 2020 | Clinical presentation, imaging and response to interferon‑alpha therapy in Erdheim–Chester disease: case‑based review | Iaremenko, O.; Petelytska, L.; Dyadyk, O.; Negria, N.; Fedkov, D. |
| 2022 | Complementary digital therapy safely improves quality of life in patients with inflammatory arthritis | Fedkov, D.; Berghofen, A.; Weiss, C.; Peine, C.; Lang, F.; Knitza, J.; Leipe, J. |
| 2022 | Correlation of clinical parameters with urinary collagen type II C-telopeptide and knee cartilage thickness measured with ultrasound in patients with knee osteoarthritis | Iaremenko, O.; Fedkov, D.; Saifullina, M.; Iaremenko, K. |
| 2019-04 | Correlation of DXA with disease duration, changes in sacroiliac joints on magnetic resonance imaging, disease activity and serum levels of sclerostin and dickkopf-1 in patients with spondyloarthritis | Iaremenko, O.; Shynkaruk, I.; Fedkov, D.; Mazanko, K. |
| 2019-06 | Dickkopf-1 serum levels and their correlation with active and chronic MRI-changes of sacroiliac joints and clinical indices in patients with spondyloarthritis | Shynkaruk, I.; Iaremenko, O.; Fedkov, D.; Iaremenko, K. |
| 2022 | Dual energy x-ray absorptiometry in patients with spondyloarthritis. Correlation with disease duration, activity and changes in sacroiliac joints on magnetic resonance imaging | Iaremenko, O.; Fedkov, D.; Mazanko, K. |
| 2022 | Efcacy and safety of a mobile app intervention in patients with infammatory arthritis: a prospective pilot study | Fedkov, D.; Berghofen, A.; Weiss, C.; Peine, C.; Lang, F.; Knitza, J.; Kuhn, S.; Krämer, B.; Leipe, J. |
| 2021 | Experience in introducing a new interactive format of lectures at clinical departments and the attitude of students towards them | Yaremenko, O.; Dobrianskyi, D.; Tarchenko, I.; Meliksetian, A.; Fedkov, D. |
| 2019-06 | Fenebrutinib compared to placebo and adalimumab in patients with inadequate response to either methotrexate therapy or prior TNF therapy: phase 2 study | StanleyCohen, C.; Tuckwell, K.; Fedkov, D. |
| 2020 | Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double‐Blind, Phase II Trial | Cohen, S.; Tuckwell, K.; Katsumoto, T.; Zhao, R.; Galanter, J.; Lee, C.; Rae, J.; Toth, B.; Ramamoorthi, N.; Hackney, J.; Berman, A.; Damjanov, N.; Fedkov, D.; Jeka, S.; Chinn, L.; Townsend, M.; Morimoto, A.; Genovese, M. |
| 2021 | Low back pain in men and women without spondyloarthritis | Iaremenko, O.; Mazanko, K.; Fedkov, D.; Dobrianskyi, D.; Smirnova, O.; Zhukova, V. |
| 2022 | Relationship of urinary collagen type II C-telopeptide and knee cartilage thickness measured with ultrasound in patients with knee osteoarthritis | Iaremenko, O.; Fedkov, D.; Saifullina, M.; Sydorova, A.; Iaremenko, K. |
